$18.08
Price
$3.0B
Market Cap
—
P/E Ratio
-5.4
Forward P/E
$-3.62
EPS (TTM)
—
Dividend Yield
$792M
Cash
$24M
Total Debt
165M
Shares Out
$6.36
$25.00
52-Week Range
Institutional Ownership of DYNE THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for DYNE THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for DYNE THERAPEUTICS INC
6 Months Insider Sentiment
Buy $0
Sell $184K
0
Buys
8
Sells
-184K
Net
0
Grants
Largest
$55K
Cox
$47K
Kerr
$35K
Cox
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 05, 2025 | John Cox | CEO & President | SELL | 2.7K | $20.72 | $55K |
| Dec 05, 2025 | Johanna Friedl-Naderer | Chief Commercial Officer | SELL | 144 | $20.72 | $3K |
| Dec 05, 2025 | Douglas Kerr | Chief Medical Officer | SELL | 880 | $20.72 | $18K |
| Sep 05, 2025 | Johanna Friedl-Naderer | Chief Commercial Officer | SELL | 144 | $13.41 | $2K |
| Sep 05, 2025 | Douglas Kerr | Chief Medical Officer | SELL | 873 | $13.41 | $12K |
| Sep 05, 2025 | John Cox | CEO & President | SELL | 2.6K | $13.41 | $35K |
| Sep 04, 2025 | Johanna Friedl-Naderer | Chief Commercial Officer | SELL | 894 | $13.27 | $12K |
| Sep 04, 2025 | Douglas Kerr | Chief Medical Officer | SELL | 3.6K | $13.27 | $47K |